Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
PLoS Biol ; 18(1): e3000585, 2020 01.
Article in English | MEDLINE | ID: mdl-31905199

ABSTRACT

It was recently suggested that supplying the brain with new neurons could counteract Alzheimer's disease (AD). This provocative idea requires further testing in experimental models in which the molecular basis of disease-induced neuronal regeneration could be investigated. We previously found that zebrafish stimulates neural stem cell (NSC) plasticity and neurogenesis in AD and could help to understand the mechanisms to be harnessed for developing new neurons in diseased mammalian brains. Here, by performing single-cell transcriptomics, we found that amyloid toxicity-induced interleukin-4 (IL4) promotes NSC proliferation and neurogenesis by suppressing the tryptophan metabolism and reducing the production of serotonin. NSC proliferation was suppressed by serotonin via down-regulation of brain-derived neurotrophic factor (BDNF)-expression in serotonin-responsive periventricular neurons. BDNF enhances NSC plasticity and neurogenesis via nerve growth factor receptor A (NGFRA)/ nuclear factor 'kappa-light-chain-enhancer' of activated B-cells (NFkB) signaling in zebrafish but not in rodents. Collectively, our results suggest a complex neuron-glia interaction that regulates regenerative neurogenesis after AD conditions in zebrafish.


Subject(s)
Alzheimer Disease , Cell Communication/physiology , Nerve Regeneration/physiology , Neurogenesis/physiology , Neuroglia/physiology , Neurons/physiology , Age Factors , Alzheimer Disease/genetics , Alzheimer Disease/pathology , Alzheimer Disease/physiopathology , Animals , Animals, Genetically Modified , Brain/metabolism , Brain/physiology , Brain-Derived Neurotrophic Factor/genetics , Brain-Derived Neurotrophic Factor/metabolism , Disease Models, Animal , Male , Mice , Mice, Transgenic , Nerve Regeneration/genetics , Neural Stem Cells/pathology , Neural Stem Cells/physiology , Neuroimmunomodulation/physiology , Neuronal Plasticity/physiology , Receptors, Nerve Growth Factor/genetics , Receptors, Nerve Growth Factor/metabolism , Serotonin/genetics , Serotonin/metabolism , Signal Transduction/genetics , Zebrafish , Zebrafish Proteins/genetics , Zebrafish Proteins/metabolism
2.
Nat Commun ; 14(1): 6346, 2023 10 10.
Article in English | MEDLINE | ID: mdl-37816738

ABSTRACT

Humans and other tetrapods are considered to require apical-ectodermal-ridge (AER) cells for limb development, and AER-like cells are suggested to be re-formed to initiate limb regeneration. Paradoxically, the presence of AER in the axolotl, a primary model organism for regeneration, remains controversial. Here, by leveraging a single-cell transcriptomics-based multi-species atlas, composed of axolotl, human, mouse, chicken, and frog cells, we first establish that axolotls contain cells with AER characteristics. Further analyses and spatial transcriptomics reveal that axolotl limbs do not fully re-form AER cells during regeneration. Moreover, the axolotl mesoderm displays part of the AER machinery, revealing a program for limb (re)growth. These results clarify the debate about the axolotl AER and the extent to which the limb developmental program is recapitulated during regeneration.


Subject(s)
Ambystoma mexicanum , Chickens , Humans , Animals , Mice , Extremities , Ectoderm , Gene Expression Regulation, Developmental
3.
Front Cell Dev Biol ; 8: 114, 2020.
Article in English | MEDLINE | ID: mdl-32181251

ABSTRACT

Recent findings suggest that reduced neurogenesis could be one of the underlying reasons for the exacerbated neuropathology in humans, thus restoring the neural stem cell proliferation and neurogenesis could help to circumvent some pathological aspects of Alzheimer's disease. We recently identified Interleukin-4/STAT6 signaling as a neuron-glia crosstalk mechanism that enables glial proliferation and neurogenesis in adult zebrafish brain and 3D cultures of human astroglia, which manifest neurogenic properties. In this study, by using single cell sequencing in the APP/PS1dE9 mouse model of AD, we found that IL4 receptor (Il4r) is not expressed in mouse astroglia and IL4 signaling is not active in these cells. We tested whether activating IL4/STAT6 signaling would enhance cell proliferation and neurogenesis in healthy and disease conditions. Lentivirus-mediated expression of IL4R or constitutively active STAT6VT impaired the survival capacity of mouse astroglia in vivo but not in vitro. These results suggest that the adult mouse brain generates a non-permissive environment that dictates a negative effect of IL4 signaling on astroglial survival and neurogenic properties in contrast to zebrafish brains and in vitro mammalian cell cultures. Our findings that IL4R signaling in dentate gyrus (DG) of adult mouse brain impinges on the survival of DG cells implicate an evolutionary mechanism that might underlie the loss of neuroregenerative ability of the brain, which might be utilized for basic and clinical aspects for neurodegenerative diseases.

4.
Front Cell Neurosci ; 13: 23, 2019.
Article in English | MEDLINE | ID: mdl-30809125

ABSTRACT

Astrocytes are abundant cell types in the vertebrate central nervous system and can act as neural stem cells in specialized niches where they constitutively generate new neurons. Outside the stem cell niches, however, these glial cells are not neurogenic. Although injuries in the mammalian central nervous system lead to profound proliferation of astrocytes, which cluster at the lesion site to form a gliotic scar, neurogenesis does not take place. Therefore, a plausible regenerative therapeutic option is to coax the endogenous reactive astrocytes to a pre-neurogenic progenitor state and use them as an endogenous reservoir for repair. However, little is known on the mechanisms that promote the neural progenitor state after injuries in humans. Gata3 was previously found to be a mechanism that zebrafish brain uses to injury-dependent induction of neural progenitors. However, the effects of GATA3 in human astrocytes after injury are not known. Therefore, in this report, we investigated how overexpression of GATA3 in primary human astrocytes would affect the neurogenic potential before and after injury in 2D and 3D cultures. We found that primary human astrocytes are unable to induce GATA3 after injury. Lentivirus-mediated overexpression of GATA3 significantly increased the number of GFAP/SOX2 double positive astrocytes and expression of pro-neural factor ASCL1, but failed to induce neurogenesis, suggesting that GATA3 is required for enhancing the neurogenic potential of primary human astrocytes and is not sufficient to induce neurogenesis alone.

5.
Dev Cell ; 46(1): 85-101.e8, 2018 07 02.
Article in English | MEDLINE | ID: mdl-29974866

ABSTRACT

Neural stem cells (NSCs) constitute an endogenous reservoir for neurons that could potentially be harnessed for regenerative therapies in disease contexts such as neurodegeneration. However, in Alzheimer's disease (AD), NSCs lose plasticity and thus possible regenerative capacity. We investigate how NSCs lose their plasticity in AD by using starPEG-heparin-based hydrogels to establish a reductionist 3D cell-instructive neuro-microenvironment that promotes the proliferative and neurogenic ability of primary and induced human NSCs. We find that administration of AD-associated Amyloid-ß42 causes classical neuropathology and hampers NSC plasticity by inducing kynurenic acid (KYNA) production. Interleukin-4 restores NSC proliferative and neurogenic ability by suppressing the KYNA-producing enzyme Kynurenine aminotransferase (KAT2), which is upregulated in APP/PS1dE9 mouse model of AD and in postmortem human AD brains. Thus, our culture system enables a reductionist investigation of regulation of human NSC plasticity for the identification of potential therapeutic targets for intervention in AD.


Subject(s)
Amyloid beta-Peptides/metabolism , Cell Plasticity/physiology , Interleukin-4/metabolism , Neural Stem Cells/cytology , Neurogenesis/physiology , Adult , Aged, 80 and over , Alzheimer Disease , Animals , Brain/metabolism , Cell Proliferation/physiology , Cells, Cultured , Disease Models, Animal , Female , Humans , Kynurenic Acid/metabolism , Male , Mice , Mice, Transgenic , Middle Aged , Neural Stem Cells/physiology , Neurons/cytology , Transaminases/metabolism , Transcriptional Activation/genetics , Young Adult
6.
Sci Rep ; 7(1): 12959, 2017 10 11.
Article in English | MEDLINE | ID: mdl-29021554

ABSTRACT

Microtubule-associated TAU protein is a pathological hallmark in Alzheimer's disease (AD), where hyperphosphorylation of TAU generates neurofibrillary tangles. To investigate the effects of TAU in a regenerative adult vertebrate brain system, we generated a cre/lox-based transgenic model of zebrafish that chronically expresses human TAUP301L, which is a variant of human TAU protein that forms neurofibrillary tangles in mouse models and humans. Interestingly, we found that although chronic and abundant expression of TAUP301L starting from early embryonic development led to hyperphosphorylation, TAUP301L did not form oligomers and neurofibrillary tangles, and did not cause elevated apoptosis and microglial activation, which are classical symptoms of tauopathies in mammals. Additionally, TAUP301L neither increased neural stem cell proliferation nor activated the expression of regenerative factor Interleukin-4, indicating that TAUP301L toxicity is prevented in the adult zebrafish brain. By combining TAUP301L expression with our established Aß42 toxicity model, we found that Aß42 ceases to initiate neurofibrillary tangle formation by TAUP301L, and TAUP301L does not exacerbate the toxicity of Aß42. Therefore, our results propose a cellular mechanism that protects the adult zebrafish brain against tauopathies, and our model can be used to understand how TAU toxicity can be prevented in humans.


Subject(s)
Aging/metabolism , Brain/metabolism , Mutant Proteins/metabolism , Neurofibrillary Tangles/metabolism , Zebrafish/metabolism , tau Proteins/metabolism , Amyloid beta-Peptides/toxicity , Animals , Animals, Genetically Modified , Behavior, Animal , Cell Death , Humans , Inflammation/pathology , Larva/metabolism , Models, Biological , Nerve Regeneration/drug effects , Neurons/metabolism , Phenotype , Phosphorylation , Proliferating Cell Nuclear Antigen/metabolism , Protein Multimerization , Stem Cells/metabolism
7.
Psychother Psychosom Med Psychol ; 54(12): 457-70, 2004 Dec.
Article in German | MEDLINE | ID: mdl-15551190

ABSTRACT

The following article is addresses the applications and functions of music therapy in the acute and rehabilitative phases of treatment of adult cancer patients. It is based on a literature review with a focus on the state of empirical research in the oncology sector of music therapy and consequences for the concepts of music therapy. First the basic aspects of music therapy treatment are explained to clarify the different research methods and to examine the special demands of oncology patients. Furthermore, a brief summary of the approaches of music therapy research in the most renowned educational institutions in Germany are outlined. The results of the studies and case histories are summarized and evaluated and provide the basis for the conclusions and recommendations for the music therapeutic practice in oncology.


Subject(s)
Music Therapy , Neoplasms/therapy , Germany , Humans , Neoplasms/psychology
SELECTION OF CITATIONS
SEARCH DETAIL